The results of trabeculectomy in patients with glaucoma secondary to uveitis are poor, but the exact cause of this remains unknown. Therefore, a study was undertaken to determine differences between conjunctiva from patients with glaucoma secondary to uveitis and that from In selected patients with glaucoma, trabeculectomy is a highly successful surgical procedure for the control of intraocular pressure (lOP). A success rate of 98% has recently been reported in a group of patients with primary open angle glaucoma (POAG) treated by primary trabecu lectomy.1 Certain groups of patients, however, do not fare so well; race,2-4 age,S previous ocular surgeryfr-8 and secondary glaucoma9--11 are all risk factors associated with filtration failure.
In selected patients with glaucoma, trabeculectomy is a highly successful surgical procedure for the control of intraocular pressure (lOP). A success rate of 98% has recently been reported in a group of patients with primary open angle glaucoma (POAG) treated by primary trabecu lectomy.1 Certain groups of patients, however, do not fare so well; race,2-4 age,S previous ocular surgeryfr-8 and secondary glaucoma9--11 are all risk factors associated with filtration failure.
In most patients who undergo successful filtration sur-gery, the conjunctiva forms a filtering bleb as draining aqueous accumulates in the subconjunctival space. Failure of filtration surgery is, in many cases, due to conjunctival fibroblast proliferation, collagen synthesis and subcon junctival fibrosis, resulting in bleb failure. 12 In clinical practice such failure tends to occur either early (within the first few post-operative months) or late (often after several years). Early-onset failure is associated with a hypercel lular response within the bleb, characterised by inflam mation and an increase in the number of active fibroblasts. This contrasts with the findings in late-onset failure, which is characterised by blockage with fibrin and hypo cellular fibrous tissue. 13 In patients with glaucoma secon dary to uveitis, ocular inflamm ation is thought to enhance subconjunctival wound healing following filtration sur gery and excessive wound healing increases the risk of bleb failure, which is usually early in onset. This may explain why the outcome of trabeculectomy in patients with uveitic glaucoma is poor.I4-19 Although adminis tration of subconjunctival 5-fluorouracil (5-FU), aimed at reducing post-operative wound healing, has been reported to be of use in certain high-risk cases,20 our findings indi cate that in patients with uveitis the benefits are negligible. 21 The aim of this study was to compare the cellular con tent of the conjunctiva from patients with uveitic glau coma with that of patients with POAG in order to determine whether any differences in the resident cell population of the conjunctiva and potential cellular mech anisms within the conjunctiva could explain the poor results of trabeculectomy and the poor response to 5-FU in these patients.
PATIENTS AND METHODS

Patients
Conjunctival biopsy specimens were obtained at the time of filtration surgery from 30 patients with glaucoma attending Moorfields Eye Hospital, London. The patients were subdivided into three groups depending on the cause of glaucoma and the regimen of medical therapy they had been treated with prior to surgery.
Group A, the uveitic group, consisted of 10 patients with uveitis and secondary glaucoma requiring trabecu lectomy. Five of these patients had an anterior uveitis and 5 an intermediate or posterior uveitis ( Table I ). The demo graphic data for the patients in each of the three groups is summarised in Table II . The patients in each group were matched as closely as possible but despite selection of relatively young POAG patients, those in group A were significantly younger than those of either group B or group C. The patients had been treated for variable durations with topical steroids (0-8 years) and topical beta-blocker (2 months-8 years) (Table II) .
Group B, the primary surgery or control group, con sisted of 10 patients with POAG who underwent planned primary trabeculectomy within 6 weeks of the diagnosis of glaucoma. These patients had been treated with topical medication for a maximum of only 6 weeks whilst waiting for surgery and were matched as closely as possible to the patients in group A (Table II) .
In view of the growing evidence that previous topical antiglaucoma medications have an adverse effect on the conjunctiva22 and outcome of filtration surgery23-25 a further control group was selected. Group C consisted of 10 patients with POAG who had been treated with a top ical beta-blocker alone for a minimum of 2 months. These 
patients were matched as closely as possible with those in group A, in particular with respect to the duration of top ical therapy (Table II) . None of the 30 patients had any additional ocular disease and none had undergone previous ocular surgery.
Methods
All patients underwent a Cairns type trabeculectomy with a Watson modification.26 Specimens of superior bulbar conjunctiva were obtained with minimal trauma from the nasal or temporal edge of the conjunctival flap at the time of surgery. Specimen size varied from about 1 mm3 to 5 mm3, smaller biopsies being taken when it was felt that larger specimens would compromise the outcome of surgery.
The biopsies were immediately fixed in 2.5% phos phate-buffered glutaraldehyde. After a minimum of 24 hours they were post-fixed in 1 % buffered osmium tetrox ide, dehydrated through graded alcohols and embedded in epoxy resin (Araldite, Agar Scientific, Stanstead, UK). Semi-thin sections 0.5 /..l m thick were cut using an ultra microtome (Reichert-Jung Ultracut E, Leica UK, Milton Keynes, UK) and stained with toluidine blue.
Light microscopic analysis of the specimens was per formed using the xl00/1.25, oil-immersion objective of a standard light microscope (Vickers Instruments, Dartford, UK) and xlO eyepieces fitted with an indexed square grating graticule (Agar Scientific, Stanstead, UK).
For each specimen the numbers of goblet cells, pale basal cells, lymphocytes, macrophages and intra-epithe lial cysts were counted in the epithelial layer and the numbers of fibroblasts, macrophages, lymphocytes, plasma cells, mast cells and granulocytes were counted in the conjunctival substantia propria.
Cell counting and identification were established using rigid criteria. Cells were only counted when both nuclear and cytoplasmic morphology made clear identification of cell type possible. Within the epithelium, basal pale cells were counted. These include both melanocytes and Lan gerhans cells, which cannot be distinguished by toluidine blue staining. All intra-epithelial cysts were counted, most being hyaline body cystS.27 All counts were made in a masked fashion and some specimens were counted twice, enabling an intra-observer/sampling error to be deter mined. This error was < 10% for all cell types.
Cell counts were based on 20 field lengths of epithelium (2 mm) and 20 field areas (0.2'mm2) of subepithelial tis sue. With all the specimens a count was made in the epi thelium and superficial substantia propria (the most superficial 0.1 mm). When possible a further count w � s made in deep substantia propria (>0.1 mm from the epI thelial basement membrane). With two specimens a deep count was not possible because of insufficient depth of biopsied tissue. In. the majority of cases at least three or four sections per specimen had to be assessed in order to obtain an adequate.area of conjunctiva for analysis. There The area of any vessels within the substantia propria, organised lymphocytic follicles or tissue artefacts within fields of assessment were determined for each observed field using the square-grating eyepiece graticule. An equivalent area of extravascular tissue was then assessed over and above the 20 field areas such that each cell count represented the number of cells in 0.2 mm2 of extravas cular connective tissue. Thus, cells within vessels were not counted. 
Statistical Analysis
Non-parametric statistics (Mann-Whitney V-test) were used to compare cell counts between the patient groups using the C-Stat statistical package (Ox tech, Oxford, UK).
RESULTS
Cell counts for the three regions of conjunctiva are shown in Fig. 1 . In comparison with conjunctiva from the primary trabeculectomy group (group B) uveitic conjunc tiva (group A) was found to contain significantly more fibroblasts and lymphocytes throughout the substantia propria and significantly more macrophages within the epithelium (Table III) . Fig. 2 shows a section of con junctiva taken from a patient with POAG who underwent a primary trabeculectomy. The subepithelial tissue is rela tively acellular in comparison with that shown in Fig. 3 from a patient with glaucoma secondary to uveitis. By comparing conjunctiva from the primary trabecu lectomy group (group B) with that from patients treated with topical beta-blockers alone (group C) it was found that the use of topical beta-blockers had little effect on the cell populations apart from the numbers of mast cells in the substantia propria. From these counts it appears that topical beta-blockers reduce the number of deep mast cells and increase the number of superficial mast cells (Table  IV) . Fig. 4 shows a section of conjunctiva taken from a patient with POAG treated with topical beta-blockers. A number of mast cells can be seen in the superficial sub stantia propria.
Since the effect of topical beta-blockers on most con junctival cell numbers was insignificant a comparison between uveitic conjunctiva (group A) and matched beta blocker conjunctiva (group C) (Table V) was little differ ent from that between uveitic conjunctiva (group A) and (Table III) . Again, uveitis was associated with an increased number of fibroblasts (in superficial, but not deep, substantia propria), lymphocytes (in all regions) and macrophages (within the epithelium). In addition uveitis was associated with an increased number of mast cells in the deep substantia propria.
DISCUSSION
Glaucoma secondary to uveitis is known to be a risk factor for failure of filtration surgery.I4-19 The exact mechanism for this failure remains unknown, but since failure tends to be early in onset a stimulus for fibroblast proliferation is suspected. Herschler et al. 28 have shown that normal aque ous has an inhibitory effect on subconjunctival fibroblast proliferation and that in patients undergoing filtration sur gery a positive relationship exists between surgical suc cess and the fibroblast inhibitory activity of their aqueous. Intraocular inflammation with associated breakdown of the blood-aqueous barrier may result in aqueous with dif ferent properties from normal. Uveitic aqueous may thus contain factors which promote fibroblast proliferation, either directly or indirectly by inhibition of the nonnal inhibitory factor.
Since patients with glaucoma secondary to uveitis have invariably experienced chronic inflammation any abnormality of aqueous, or other extracellular ocular fluids, will be long standing by the time filtration surgery is required. Fibroblast proliferation may thus have been stimulated for some time prior to surgery. Our findings agree with such a hypothesis, in that the number of fibro blasts present in uveitic conjunctiva is significantly higher than in 'normal' conjunctiva. An increase in the popula tion of resident fibroblasts at the time of filtration surgery may result in an exaggerated wound healing response in the post-operative period and explain, at least partially, the relatively high failure rate of trabeculectomy in patients with glaucoma secondary to uveitis.
The increase in number of fibroblasts may not be due to a direct effect of any aqueous-borne factor alone. A more complex series of cellular interactions is probably involved. Our results have shown that in addition to fibro blasts, the number of lymphocytes is also significantly increased in uveitic conjunctiva. This increase may be induced by an aqueous-borne factor, or alternatively may be a primary feature of the uveitic disease process. The increase in number of fibroblasts may occur secondary to the increase in lymphocyte numbers. T-Iymphocytes are known to participate in wound heal ing. In the early phase of healing there is dynamic infiltration of both T helper/effector and T suppressor/ cytotoxic lymphocytes into the superficial areas of a wound.29 Indirect evidence that these cells play an active role, rather than a passive role in part of a generalised inflammatory cell infiltration, has been provided by in vivo studies: agents which stimulate lymphocytes, such as growth hormone, vitamin A and interleukin-2 (IL-2), have been shown to increase collagen deposition and wound breaking strength, whereas agents that inhibit lymphocyte function, such as steroid, cyclosporin A and retinoic acid, reduce fibrosis. 30 The main role of the T-Iymphocyte in wound healing appears to be as a moderating or control ling cell, since the process can be initiated and completed in the absence of T-Iymphocytes, albeit less effec tively.3o,3! There is also evidence that different T-Iympho cyte subsets have differing effects on wound healing.32 Under normal circumstances, stimulatory and inhibitory T-Iymphocyte effects on wound cellular activity are well balanced and it may be an imbalance in this control which is responsible for the excessive fibrosis in patients with uveitic glaucoma undergoing filtration surgery. Activated T-Iymphocytes are able to induce recruitment, prolifer ation and activation of fibroblasts.33 This control may occur via lymphokines acting directly on fibroblasts. In vitro studies have shown that various lymphokines can either stimulate (e.g. transforming growth factor-� (TGF-�), fibroblast activating factor) or inhibit (e.g. alpha and gamma interferon, fibroblast inhibitory factor) fibro blast activity in terms of proliferation, chemotaxis and collagen synthesis. 33 In vivo studies have provided further evidence, and in animal models TGF-� has been shown to increase granulation tissue formation, collagen deposition and wound breaking strength.34-36 TGF-� is considered to be one of the most potent stimuli of fibroblast synthetic activity.37 Relative overproduction of stimulatory lympho kines such as TGF-� may be the cause of excessive fibro sis in patients with uveitic glaucoma.
Alternatively T-Iymphocytes may stimulate fibroblasts by an indirect effect on other cells, such as macrophages.
In support of this is the fact that lymphokines can trigger the release of macrophage-derived fibrogenic cytokines. 38 Although only significant in the conjunctival epithelium, our results have shown a tendency for uveitic conjunctiva to contain more macrophages than control tissue. The number of cells, however, is not the only crucial factor and the degree of cellular activation is equally, if not more important. Indeed, resident macrophages are suppressive of fibroblast function, while activated macrophages are stimulatory.3! Macrophages play a key role in wound heal ing by phagocytosis (removal of damaged and exogenous material), generation of chemotactic factors which recruit inflammatory cells, production of cytokines and accumu-D. C. BROADWAY ET AL. lation and proliferation of fibroblasts and endothelial cells. 39,4o Macrophages are thought to be a principal source of fibrogenic cytokines such as platelet-derived growth factor, tumour necrosis factor, TGF-a and TGF_�,40--4 3 so that activation of such cells is critical for normal wound healing and amplified macrophage activity may result in excessive wound healing.
More work is required to determine the degree of acti vation of the various cell populations. It is, however, pro posed that in patients with glaucoma secondary to uveitis the wound healing response is up-regulated by an increase in the number and degree of activation of inflammatory cells (especially lymphocytes and macrophages), which in tum increases the number and activity of fibroblasts. The response may be achieved by a direct effect of lympho kines, indirectly via the mediation of macrophages, or by both pathways.
Our results suggest that cellular changes in the con junctiva of patients with glaucoma secondary to uveitis may be partly responsible for the poor results of trabecu lectomy. In addition they may explain the poor response to post-operative subconjunctival injections of 5-FU. 5-FU inhibits fibroblast proliferation44 and for its effect to be significant in these patients it has to outweigh any stim ulatory effect of uveitic aqueous, or have a greater effect due to the higher number of resident fibroblasts and inflammatory cells. Further studies are required to deter mine whether changes in the peri-operative management of these patients, aimed at a conjunctival level, can improve success rates. In view of the potential importance of conjunctival lymphocytes and other inflammatory cells in these patients, peri-operative treatment with systemic steroids, or other immunosuppressive agents such as cyclosporin, in addition to topical steroids may prove useful.
